- Home
- / Clene Nanomedicine
Clene Nanomedicine
Clene Nanomedicine Summary
Company Summary
- Overview
- Clene Nanomedicine is a company that develops drugs designed to treat neurodegenerative diseases. Its drug is a concentrated, aqueous suspension of clean-surfaced faceted nanocrystalline gold that acts catalytically to assist intracellular biological reactions.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2013
- HQ
- Holladay, UT, US | view all locations
- Website
- https://clene.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Mark Mortenson, Chief Science Officer
Michael Hotchkin, Chief Development Officer
Jerry Miraglia, General Counsel and Corporate Secretary
LocationsView all
2 locations detected
Holladay, UT HQ
United States
6550 Millrock Dr g50
North East, MD
United States
500 Principio Pkwy W #400